STORY: Shares of Eli Lilly jumped Thursday morning after the company, known for its popular weight-loss drug Zepbound, forecast annual profit largely above Wall Street estimates.The outlook appeared ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales of ...
16h
Cycling News on MSNVolta a Valenciana: Santiago Buitrago climbs to victory on stage 2 summit finishSantiago Buitrago gave Bahrain Victorious their first win of 2025 on the Alto de Partegat hilltop finish at the Volta a Valenciana, catching and passing teammate Pello Bilbao in the final kilometre.
If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results